A. Chiappa

Central nervous system complications associated with immune checkpoint inhibitors

F. Ducray, C. Marchal, J. Honnorat, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort.

G. Jeannin, R. Descourt, R. Gervais, 2020, Lung cancer.

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

Nancy E. Marion, B. Delclaux, B. Asselain, 2022, The Lancet regional health. Europe.

Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study)

C. Chouaid, A. Vergnenègre, C. Dubos-Arvis, 2017, Targeted Oncology.

[Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial].

G. Noël, J. Mazeron, A. Chiappa, 1999, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer

P. Fournel, G. Quéré, C. Chouaid, 2019, Targeted Oncology.

Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis

R. Gervais, A. Vergnenègre, G. Robinet, 2021, Therapeutic advances in medical oncology.

Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study)

C. Chouaid, A. Vergnenègre, C. Dubos-Arvis, 2017, Targeted Oncology.